Department of Psychiatry and Behavioural Neurosciences, McMaster University, Hamilton, Ontario, Canada.
Women's Health Concerns Clinic, St. Joseph's Healthcare Hamilton, Ontario, Canada.
Menopause. 2019 Sep;26(9):972-980. doi: 10.1097/GME.0000000000001363.
To evaluate the effectiveness of cognitive behavioral therapy for menopausal symptoms (CBT-Meno) compared with a waitlist condition (no active intervention). A randomized controlled trial was conducted with 71 perimenopausal or postmenopausal women who were seeking treatment for menopausal symptoms.
Blind assessments were conducted at baseline, 12 weeks postbaseline, and 3 months post-treatment. An intention-to-treat analysis was conducted. CBT-Meno sessions included psychoeducation, and cognitive and behavioral strategies for vasomotor and depressive symptoms, anxiety, sleep difficulties, and sexual concerns. Primary outcomes were scores on the Hot Flash Related Daily Interference Scale (HFRDIS) and Beck Depression Inventory (BDI-II). Secondary outcomes were scores assessing vasomotor and sexual concerns on the Greene Climacteric Scale (GCS-vm, GCS-sex), the Montgomery-Åsberg Depression Rating Scale (MADRS), Hamilton Anxiety Rating Scale (HAM-A), Pittsburgh Sleep Quality Index (PSQI), and the Female Sexual Function Index (FSFI).
There were significantly greater improvements in CBT-Meno compared with waitlist in vasomotor symptom interference (HFRDIS; P < 0.001, ηP = 0.21) and "bothersomeness" (GCS-vm; P = 0.04, ηP = 0.06), depressive symptoms (BDI-II; P = 0.001, ηP = 0.15), sleep difficulties (PSQI; P = 0.001, ηP = 0.17), and sexual concerns (GCS-sex; P = 0.03, ηP = 0.07). These results were found even when controlling for menopausal staging and medication use. Gains were maintained at 3 months post-treatment.
CBT-Meno was particularly effective in improving self-reported vasomotor symptoms, depressive symptoms, sleep difficulties, and sexual concerns. Although future studies will be needed to confirm the impact of CBT-Meno on anxiety symptoms, these results suggest that this protocol is effective in targeting commonly reported menopausal symptoms. : Video Summary: Supplemental Digiatl Content 1, http://links.lww.com/MENO/A416.
评估认知行为疗法(CBT-Meno)对绝经期症状的有效性,与等待名单条件(无主动干预)进行比较。对 71 名正在接受绝经期症状治疗的围绝经期或绝经后妇女进行了一项随机对照试验。
在基线、基线后 12 周和治疗后 3 个月进行盲法评估。进行了意向治疗分析。CBT-Meno 课程包括心理教育以及血管舒缩和抑郁症状、焦虑、睡眠困难和性问题的认知和行为策略。主要结局指标是潮热相关日常生活干扰量表(HFRDIS)和贝克抑郁量表第二版(BDI-II)的评分。次要结局指标是评估绝经期症状的量表评分,包括格林更年期量表(GCS-vm、GCS-sex)、蒙哥马利-阿斯伯格抑郁评定量表(MADRS)、汉密尔顿焦虑评定量表(HAM-A)、匹兹堡睡眠质量指数(PSQI)和女性性功能指数(FSFI)。
与等待名单相比,CBT-Meno 组在血管舒缩症状干扰(HFRDIS;P<0.001,ηP=0.21)和“烦恼”(GCS-vm;P=0.04,ηP=0.06)、抑郁症状(BDI-II;P=0.001,ηP=0.15)、睡眠困难(PSQI;P=0.001,ηP=0.17)和性问题(GCS-sex;P=0.03,ηP=0.07)方面有显著的改善。这些结果甚至在控制绝经分期和药物使用的情况下也是如此。在治疗后 3 个月时仍保持获益。
CBT-Meno 特别有效地改善了自我报告的血管舒缩症状、抑郁症状、睡眠困难和性问题。尽管需要进一步的研究来确认 CBT-Meno 对焦虑症状的影响,但这些结果表明,该方案在针对常见的绝经期症状方面是有效的。